Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,821 | -6,915 | -3,985 | -6,999 | -2,821 |
| Depreciation Amortization | 12 | 50 | 4 | 98 | 94 |
| Income taxes - deferred | N/A | N/A | N/A | -382 | N/A |
| Accounts payable and accrued liabilities | 362 | -105 | 1,359 | -1,978 | -1,522 |
| Other Working Capital | 2,360 | -222 | 911 | -3,033 | -514 |
| Other Operating Activity | -432 | -75 | -1,453 | -5,782 | -7,792 |
| Operating Cash Flow | $-8,520 | $-7,268 | $-3,164 | $-18,074 | $-12,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 275 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 29,107 | 29,107 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $29,382 | $29,107 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,827 | 12,041 | 12,041 | 750 | 750 |
| Financing Cash Flow | $29,827 | $12,041 | $12,041 | $750 | $750 |
| Beginning Cash Position | 12,162 | 12,162 | 12,162 | 104 | 104 |
| End Cash Position | 33,469 | 16,935 | 21,038 | 12,162 | 17,407 |
| Net Cash Flow | $21,307 | $4,773 | $8,876 | $12,058 | $17,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,520 | -7,268 | -3,164 | -18,074 | -12,554 |
| Free Cash Flow | -8,520 | -7,268 | -3,164 | -18,074 | -12,554 |